Back to search
Rheumatoid Purpura
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rheumatoid Purpura trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rheumatoid Purpura trials you may qualify forThis study is an open-label, multiple-dose escalation, Investigator-Initiated Trial (IIT) clinical trial designed to evaluate the safety and tolerability of CC3…
The objective of this study is to evaluate the efficacy and safety of BCMA/CD19 chimeric antigen receptor (CAR)-modified T cells in the treatment of autoimmune…
The purpose of this registration is to list Managed Access Programs (MAPs) related to VAY736, ianalumab
The purpose of this study is to assess the safety and efficacy of CD19 UCAR-T cell therapy in Subjects with autoimmune diseases.
The main objective of this study is to describe the management of children with rheumatoid purpura from admission to the pediatric emergency room to follow-up b…